Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2399-3642

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes ; volume:1 ; number:1 ; day:6 ; month:8 ; year:2018 ; pages:1-18 ; date:12.2018
Communications biology ; 1, Heft 1 (6.8.2018), 1-18, 12.2018

Creator: Shahzad, Khurrum

Contributor: Gadi, Ihsan
Nazir, Sumra
Al-Dabet, Moh’d Mohanad
Kohli, Shrey
Bock, Fabian
Breitenstein, Lukas
Ranjan, Satish
Fuchs, Tina
Halloul, Zuhir
Nawroth, Peter. P.
Pelicci, Pier Giuseppe
Braun-Dullaeus, Ruediger C.
Camerer, Eric
Esmon, Charles T.
Isermann, Berend
SpringerLink (Online service)

DOI: 10.1038/s42003-018-0108-5

URN: urn:nbn:de:101:1-2018100220585421962602

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Shahzad, Khurrum
Gadi, Ihsan
Nazir, Sumra
Al-Dabet, Moh’d Mohanad
Kohli, Shrey
Bock, Fabian
Breitenstein, Lukas
Ranjan, Satish
Fuchs, Tina
Halloul, Zuhir
Nawroth, Peter. P.
Pelicci, Pier Giuseppe
Braun-Dullaeus, Ruediger C.
Camerer, Eric
Esmon, Charles T.
Isermann, Berend
SpringerLink (Online service)

Other Objects (12)

Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes mellitus

Macrophages in atheromatous plaque developmental stages

A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Ferroptosis: A potential target of macrophages in plaque vulnerability

Can we be epigenetically proactive?

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer

Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages

A Lipid-Structured Model of Atherosclerotic Plaque Macrophages with Lipid-Dependent Kinetics

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

Polymer‐Functionalized Mitochondrial Transplantation to Plaque Macrophages as a Therapeutic Strategy Targeting Atherosclerosis

Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes mellitus

Macrophages in atheromatous plaque developmental stages

A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Ferroptosis: A potential target of macrophages in plaque vulnerability

Can we be epigenetically proactive?

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer

Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages

A Lipid-Structured Model of Atherosclerotic Plaque Macrophages with Lipid-Dependent Kinetics

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

Polymer‐Functionalized Mitochondrial Transplantation to Plaque Macrophages as a Therapeutic Strategy Targeting Atherosclerosis

Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes mellitus

Macrophages in atheromatous plaque developmental stages

A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Ferroptosis: A potential target of macrophages in plaque vulnerability

Can we be epigenetically proactive?

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer

Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages

A Lipid-Structured Model of Atherosclerotic Plaque Macrophages with Lipid-Dependent Kinetics

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

Polymer‐Functionalized Mitochondrial Transplantation to Plaque Macrophages as a Therapeutic Strategy Targeting Atherosclerosis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes mellitus

Macrophages in atheromatous plaque developmental stages

A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Ferroptosis: A potential target of macrophages in plaque vulnerability

Can we be epigenetically proactive?

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer

Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages

A Lipid-Structured Model of Atherosclerotic Plaque Macrophages with Lipid-Dependent Kinetics

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

Polymer‐Functionalized Mitochondrial Transplantation to Plaque Macrophages as a Therapeutic Strategy Targeting Atherosclerosis

Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes mellitus

Macrophages in atheromatous plaque developmental stages

A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Ferroptosis: A potential target of macrophages in plaque vulnerability

Can we be epigenetically proactive?

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer

Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages

A Lipid-Structured Model of Atherosclerotic Plaque Macrophages with Lipid-Dependent Kinetics

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

Polymer‐Functionalized Mitochondrial Transplantation to Plaque Macrophages as a Therapeutic Strategy Targeting Atherosclerosis

Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes mellitus

Macrophages in atheromatous plaque developmental stages

A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages

Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway

Ferroptosis: A potential target of macrophages in plaque vulnerability

Can we be epigenetically proactive?

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer

Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages

A Lipid-Structured Model of Atherosclerotic Plaque Macrophages with Lipid-Dependent Kinetics

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

Polymer‐Functionalized Mitochondrial Transplantation to Plaque Macrophages as a Therapeutic Strategy Targeting Atherosclerosis

Related objects

Reset password